What SynergenX does

SynergenX is a US-based private healthcare services company operating a hybrid clinic-plus-digital platform focused on hormone replacement therapy and medical weight management. Founded in 2016 and headquartered in Texas, the company operates 64 physical clinic locations — historically branded as Low T Center and HerKare, and currently being consolidated under the unified SynergenX brand — across 10 states (Texas, Illinois, Arkansas, Colorado, Indiana, Missouri, North Carolina, Oklahoma, Ohio, Tennessee). The company reports having served more than 500,000 patients cumulatively. Core products include testosterone replacement therapy (TRT) for men, bioidentical hormone replacement therapy (BHRT) for women covering menopause and perimenopause, medically supervised weight loss programs using compounded semaglutide and other GLP-1/GIP therapies, peptide therapies (Sermorelin for HGH stimulation, PT-141/bremelanotide for female sexual desire), and a self-inject at-home TRT option delivered monthly.

The underlying technology layer is modest: a patient-facing mobile application (iOS and Android), a telemedicine platform for virtual consultations and follow-ups, and an InBody body composition scanning capability in-clinic. The proprietary technology surface is limited to telehealth delivery, mobile appointment management, and treatment tracking — there is no disclosed AI/ML component, data flywheel, or platform API.

SynergenX's business model combines professional services revenue (in-clinic consultations and follow-ups), treatment and medication sales (prescription hormones, GLP-1 injections, peptides), insurance billing through major carriers (Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare), and a growing self-pay / out-of-pocket stream (self-inject TRT, $99 women's hormone testing, $100 weight loss evaluation, free initial testosterone testing for men). The customer base is purely direct-to-consumer across three persona segments — men with low testosterone, women with hormonal imbalances, and weight management patients — acquired through a multi-channel mix of website/digital presence, mobile app, phone inquiries (888-219-7259), patient referrals, and earned media coverage in Forbes, CBS News, and The Economist. The company employs 51–100 staff and holds LegitScript certification for healthcare merchant compliance.

Name

SynergenX

Legal name

SynergenX

Website

https://synergenxhealth.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

51–100 employees

Short description

SynergenX is a private US healthcare operator running 64 hormone replacement and medical weight loss clinics across 10 states, serving men with low testosterone, women with hormonal imbalances, and weight management patients via in-clinic care, telemedicine, and a mobile app.

Ownership category

akta.pro rank

Product category

Hormone Replacement Therapy Clinics

NAICS

Home Health Care Services (62161)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Endocrinology & Diabetes Telemedicine Platforms (HLALAGAD)

akta.pro secondary industries

Weight Loss & Body Transformation Training (HSADAAAC), Medical Nutrition Therapy (Registered Dietitian) (HSADAFAE)

Keywords

• Hormone replacement therapy
• Testosterone replacement therapy
• Medical weight loss
• Men's health clinics
• Bioidentical hormone therapy

Headquarters

HQ city

San Antonio

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Clinic Visit Services: Revenue from in-person medical consultations at 64 clinic locations. Services include initial evaluations, follow-up visits, and ongoing treatment management.
2. Treatment and Medication Sales: Revenue from prescribing and dispensing hormone replacement therapies including testosterone replacement therapy (TRT) for men and hormone treatments for women.
3. Insurance Billing: Revenue through accepted insurance providers including Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and other major carriers. Patient responsibility varies by plan.
4. Self-Pay/Out-of-Pocket: Direct patient payments for services and treatments not covered by insurance, including self-inject TRT option and diagnostic testing.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

SynergenX provides provider-led hormone replacement therapy and medical weight loss services directly to consumers through a hybrid clinic-and-telehealth delivery model. Core offerings include testosterone replacement therapy (TRT) for men, bioidentical hormone replacement therapy (HRT) for women, medically supervised weight loss programs using compounded GLP-1/semaglutide therapies, and peptide therapies (Sermorelin and PT-141), dispensed and supervised across 64 physical clinic locations, telemedicine channels, and an at-home self-inject program.

Product overview

SynergenX is a hormone therapy and weight loss healthcare company operating a platform-plus-service model with 64 physical Low T Center clinic locations across Texas and Chicago, supplemented by telemedicine capabilities and a mobile app. The core product portfolio centers on Testosterone Replacement Therapy (TRT) for men and Hormone Replacement Therapy (HRT) for women using bioidentical hormones. These are supported by weight loss programs featuring GLP-1 and semaglutide injections, peptide therapies (Sermorelin for HGH, PT-141 for sexual dysfunction), and Self-Inject TRT for at-home administration. The company was founded in 2016 and has served over 500,000 patients, with Low T Center and HerKare clinics transitioning under the unified SynergenX brand.

Differentiator

Problem solved

Functional benefit

Products and services

• Testosterone Replacement Therapy (TRT) for Men Provider-led testosterone replacement therapy customized to each patient's unique hormone levels, symptoms, and goals. Includes in-clinic injections and an at-home self-inject option with pharmaceutical-grade testosterone cypionate, with ongoing medical supervision and follow-up.
• Hormone Replacement Therapy (HRT) for Women Bioidentical hormone replacement therapy (BHRT) for women using estrogen, progesterone, and testosterone to relieve symptoms of menopause and perimenopause. Available in topical, pellet, and injectable formulations, prescribed and supervised by SynergenX providers.
• Medical Weight Loss Programs Medically supervised weight loss programs including compounded semaglutide (GLP-1 therapy), GLP-1/GIP therapy, nutritional counseling, lipotropic injections, B12 support, and lifestyle planning, offered to qualifying patients following an initial $100 evaluation.
• Sermorelin Peptide Therapy Human growth hormone (HGH) peptide therapy using Sermorelin to stimulate the pituitary gland to produce and release the body's own growth hormone. Marketed to support energy, recovery, lean muscle development, fat metabolism, and sleep quality.
• PT-141 Peptide Therapy FDA-approved peptide therapy (bremelanotide) designed to support female sexual desire by acting on the brain's arousal pathways and targeting melanocortin receptors to help restore sexual interest and responsiveness.
• Self-Inject TRT At-home testosterone replacement therapy plan allowing qualified patients to self-administer pre-filled syringes of custom-dosed testosterone cypionate delivered monthly to their door.
• Telemedicine Services Telehealth support and remote care services enabling patients to consult with SynergenX providers virtually for follow-ups, prescription management, and ongoing treatment monitoring.
• Low T Centers (Clinic Network) Network of 64 physical clinic locations (primarily Texas and Illinois, with additional locations in Arkansas, Colorado, Indiana, Missouri, North Carolina, Oklahoma, Ohio, and Tennessee) offering in-person hormone therapy consultations, injections, body composition scans (InBody), and lab work.
• SynergenX Mobile App Patient-facing mobile application available on iOS and Android for appointment scheduling, telehealth visits, treatment tracking, and communication with the SynergenX care team.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Low T CentercoreOthersLegacy clinic network being consolidated into the SynergenX brand. 64 Low T Center locations transitioning to operate under SynergenX Health, representing the core infrastructure and patient base of the company.

Scale indicators3 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• Hims & Hers Health: Public direct-to-consumer telehealth platform offering men's TRT, women's HRT, and GLP-1 weight loss online. Most comparable scaled competitor targeting the same SynergenX patient segments (men with low T, women with hormonal symptoms, weight loss) with a digital-first, nationwide delivery model.
• Ro (Roman): Digital health company operating the Roman men's health brand for TRT and ED, plus a women's health and weight loss platform. Overlaps directly with SynergenX's core TRT/HRT/weight loss service lines and competes for the same self-pay digital patient.
• Marek Health: Men's hormone optimization and TRT clinic-plus-telehealth operator with a comparable mix of in-person consultations, lab work, and at-home self-inject testosterone. Highly analogous business model to SynergenX's TRT core product.
• Ageless Men's Health: Multi-state clinic chain specializing exclusively in men's hormone replacement therapy and related wellness. Direct physical-clinic competitor with a similar single-gender, TRT-anchored service offering.
• Defy Medical: Tampa-based hormone therapy and wellness clinic offering TRT, HRT, peptide therapy, and weight management through both in-person visits and telemedicine. Comparable combination of physician-led protocols, lab work, and at-home self-inject options.

Emerging players

• Thrivelab: Telehealth-first men's hormone therapy provider offering customized TRT programs with at-home lab kits and shipped medications. Emerging digital competitor with overlapping TRT product but no physical clinic footprint.
• MangoRx: Direct-to-consumer men's health and weight loss telehealth platform offering hormone, ED, and GLP-1-style treatments. Competes for the same self-pay digitally acquired patient SynergenX targets through its self-inject and telemedicine channels.
• Manual Men: UK-originated men's health telehealth platform offering TRT, ED, and hair loss treatments online. Comparable digital-first GTM and self-pay positioning, serving as a model for global direct-to-consumer men's hormone competitors.
• Calibrate: Telehealth metabolic health company offering physician-supervised GLP-1 weight loss programs. Directly comparable to SynergenX's medical weight loss line as a digital-first entrant in the same treatment category.

Broad incumbents

• Teladoc Health: Large incumbent virtual care provider with a broad telehealth portfolio including chronic condition management and weight management. Less specialized than SynergenX in endocrinology, but represents a scaled platform competitor that could move deeper into hormone and weight loss.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/synergenxhealth
• Facebookfacebook.com/synergenxhealth
• LinkedInlinkedin.com/company/synergenx-health

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SynergenX